izvor podataka: crosbi
!
Anti-programmed death-1 inhibitor nivolumab- induced immune-related adverse events: hepatitis, renal insufficiency, myositis, vitiligo, and hypothyroidism: a case-based review (CROSBI ID 322262)
Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija
Zekić, Tatjana ; Benić, Stanić Mirjana
Anti-programmed death-1 inhibitor nivolumab- induced immune-related adverse events: hepatitis, renal insufficiency, myositis, vitiligo, and hypothyroidism: a case-based review // Rheumatology international, 43 (2022), 3; 559-565. doi: 10.1007/s00296-022-05247-5
Podaci o odgovornosti
Zekić, Tatjana ; Benić, Stanić Mirjana
engleski
Anti-programmed death-1 inhibitor nivolumab- induced immune-related adverse events: hepatitis, renal insufficiency, myositis, vitiligo, and hypothyroidism: a case-based review
Rad prikazuje pojavu autoimunih manifesatcija kod liječenja s imunoterapijom raka PD-L1 i pregled literature.
PD-L1 Inhibitors ; Hepatitis, Toxic ; Thyroid gland ; Myositis ; Renal Insufficiency, Chronic ; Vitiligo
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o izdanju
43 (3)
2022.
559-565
objavljeno
0172-8172
1437-160X
10.1007/s00296-022-05247-5
Povezanost rada
Kliničke medicinske znanosti
Poveznice
Indeksiranost
